Post COVID-19 sequelae: A prospective observational study from Northern India

Author:

Naik Shivdas1,Haldar Soumendra Nath1,Soneja Manish1,Mundadan Netto George1,Garg Prerna1,Mittal Ankit1,Desai Devashish1,Trilangi Praveen Kumar1,Chakraborty Sayan1,Begam Nazneen Nahar1,Bhattacharya Bisakh1,Maher Ganesh1,Mahishi Niranjan1,Rajanna Chaithra1,Kumar Swasthi S1,Arunan Bharathi1,Kirtana J1,Gupta Ankesh1,Patidar Diksha1,Kodan Parul1,Sethi Prayas1,Ray Animesh1,Jorwal Pankaj1,Kumar Arvind1,Nischal Neeraj1,Sinha Sanjeev1,Biswas Ashutosh1,Wig Naveet1

Affiliation:

1. Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Reference26 articles.

1. 1. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021; 27:601-615.

2. 2. National Institute for Health and Care Excellence. COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19).(NG188). Evidence reviews 2 and 3: prevalence. 2020. https://www.nice.org.uk/guidance/ng188 (accessed June 8, 2021).

3. 3. Cares-Marambio K, Montenegro-Jiménez Y, TorresCastro R, Vera-Uribe R, Torralba Y, Alsina-Restoy X, Vasconcello-Castillo L, Valiro J. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Chron Respir Dis. 2021; 18:147997312110022.

4. 4. World Health Organization. Laboratory testing for coronavirus disease (COVID-19) in suspected human cases: interim guidance. https://apps.who.int/iris/handle/10665/331501(19 March 2020) (accessed Jun 25, 2021).

5. 5. Government of India; Ministry of Health and Family Welfare; Directorate General of Health Services (EMR Division). Clinical Management Protocol for COVID19 dated 27/06/2020. https://www.mohfw.gov.in/pdf/ClinicalManagementProtocolforCOVID19.pdf (accessed Jul 19, 2021).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3